XLO
Xilio Therapeutics·NASDAQ
--
--(--)
--
--(--)
XLO fundamentals
Xilio Therapeutics (XLO) released its earnings on Aug 14, 2025: revenue was 8.09M (YoY +243.01%), missed estimates; EPS was -2.24 (YoY +33.33%), missed estimates.
Revenue / YoY
8.09M
+243.01%
EPS / YoY
-2.24
+33.33%
Report date
Aug 14, 2025
Earnings Call
7:30 AM on Aug 14, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
XLO has released its 2025 Q4 earnings report, with revenue of 13.69M, reflecting a YoY change of 693.85%, and net profit of 10.36M, showing a YoY change of 179.13%. The Sankey diagram below clearly presents XLO's revenue sources and cost distribution.
Key Indicators
Xilio Therapeutics (XLO) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Xilio Therapeutics (XLO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Xilio Therapeutics (XLO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Xilio Therapeutics (XLO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Xilio Therapeutics (XLO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Xilio Therapeutics (XLO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Xilio Therapeutics beat or miss consensus estimates last quarter?What is Xilio Therapeutics's gross profit margin?What were the key takeaways from Xilio Therapeutics's earnings call?What is the revenue and EPS growth rate for Xilio Therapeutics year over year?What were the key takeaways from Xilio Therapeutics’s earnings call?What is the market's earnings forecast for Xilio Therapeutics next quarter?What factors drove the changes in Xilio Therapeutics's revenue and profit?What guidance did Xilio Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
